Promising Genomics & Synthetic Biology Stocks to Consider in 2025 Investors interested in the Genomics and Synthetic Biology theme should consider these stocks: Twist Bioscience Corporation, Wave Life Sciences, and…
WVE Stock Soars on Upbeat Initial Antitrypsin Deficiency Study Data Wave Life Sciences stock soars on positive initial data showing the first-ever therapeutic RNA editing in humans in the phase…
Wave Life Sciences to Present at Chardan 8th Annual Genetic Medicines Conference CAMBRIDGE, Mass., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company…
Wave Life Sciences Prices Upsized $200 Million Public Offering of Ordinary Shares and Pre-Funded Warrants CAMBRIDGE, Mass., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company…
Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants CAMBRIDGE, Mass., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company…
RBC maintains $5 target on WAVE Life Sciences shares By Investing.com RBC maintains $5 target on WAVE Life Sciences shares…
Wave Life Sciences Fourth Quarter and Full Year 2023 Financial Results Scheduled for March 6, 2024 CAMBRIDGE, Mass., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company…